Abatacept Prefilled Syringe

DRUG2 trials

Sponsors

Lille Catholic University, Tongji Hospital

Conditions

Arthritis, RheumatoidPemphigus Vulgaris

Phase 4

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

Lille Catholic UniversityArthritis, Rheumatoid

Start: 2018-01-22End: 2024-11-30Target: 224Updated: 2023-09-13

A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Tongji HospitalPemphigus Vulgaris

Start: 2021-02-01End: 2022-09-30Target: 60Updated: 2022-03-31

Related Papers

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial

BMJ Open2025-06-01